title: Do DNA double-strand breaks induced by Alu I lead to development of novel aberrations in the second and third post-treatment mitoses?
abstract: Several authors have reported that ionizing radiation can give rise to novel aberrations several mitotic divisions after the exposure. At our institute this phenomenon has been observed in mouse preimplantation embryos. This cell system is uniquely well suited for such investigations because the first three cell divisions show a high degree of synchrony. Thus the expression of chromosomal aberrations at the first, second and third mitosis after irradiation can be scored unambiguously. To investigate whether DNA double-strand breaks may be the lesions responsible for the delayed expression of chromosomal aberrations, we have studied the frequencies of aberrations in the first, second and third mitosis after treatment of one-cell mouse embryos with the restriction enzyme Alu I. Embryos were permeabilized with Streptolysin-O. The results indicate that the induction of double-strand breaks does not lead to novel aberrations in the third post-treatment mitosis. Several embryos scored at the second mitosis showed very high numbers of aberrations, indicating that Alu I may remain active in the cells for a period of one cell cycle. After treatment with Streptolysin-O alone, enhanced aberration frequencies were observed in the third post-treatment mitosis, suggesting that membrane damage has a delayed effect on the cellular integrity.
authors.affiliation: Institut für Medizinische Strahlenbiologie, Universitätsklinikum Essen, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Wojcik
authors.forename: K
authors.initials: K
authors.lastname: Bonk
authors.forename: W U
authors.initials: WU
authors.lastname: Müller
authors.forename: G
authors.initials: G
authors.lastname: Obe
authors.forename: C
authors.initials: C
authors.lastname: Streffer
mesh_terms: D000818:Animals; D002463:Cell Membrane Permeability / Q000187:drug effects; D002467:Cell Nucleus / Q000187:drug effects; D002869:Chromosome Aberrations; D002970:Cleavage Stage, Ovum; D003593:Cytoplasm; D004249:DNA Damage; D015252:Deoxyribonucleases, Type II Site-Specific / Q000008:administration & dosage*; D005260:Female; D008297:Male; D051379:Mice; D008845:Microinjections; D008938:Mitosis; D013301:Streptolysins / Q000008:administration & dosage*
chemical_list: D013301:Streptolysins; C024669:endodeoxyribonuclease AluI; D015252:Deoxyribonucleases, Type II Site-Specific